| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.4 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |